• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在生理条件下,离解度和聚乙二醇化程度对壳聚糖衍生物纳米粒子稳定性的影响。

Impact of Degree of Ionization and PEGylation on the Stability of Nanoparticles of Chitosan Derivatives at Physiological Conditions.

机构信息

Department of Chemistry and Environmental Sciences, IBILCE, São Paulo State University-UNESP, São José do Rio Preto 15054-000, SP, Brazil.

Orthopedic Research Laboratory, Hôpital du Sacré-Coeur de Montréal, Université de Montréal-Canada, Montreal, QC H3C3J7, Canada.

出版信息

Mar Drugs. 2022 Jul 25;20(8):476. doi: 10.3390/md20080476.

DOI:10.3390/md20080476
PMID:35892944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9330794/
Abstract

Nowadays, the therapeutic efficiency of small interfering RNAs (siRNA) is still limited by the efficiency of gene therapy vectors capable of carrying them inside the target cells. In this study, siRNA nanocarriers based on low molecular weight chitosan grafted with increasing proportions (5 to 55%) of diisopropylethylamine (DIPEA) groups were developed, which allowed precise control of the degree of ionization of the polycations at pH 7.4. This approach made obtaining siRNA nanocarriers with small sizes (100-200 nm), positive surface charge and enhanced colloidal stability (up to 24 h) at physiological conditions of pH (7.4) and ionic strength (150 mmol L) possible. Moreover, the PEGylation improved the stability of the nanoparticles, which maintained their colloidal stability and nanometric sizes even in an albumin-containing medium. The chitosan-derivatives displayed non-cytotoxic effects in both fibroblasts (NIH/3T3) and macrophages (RAW 264.7) at high N/P ratios and polymer concentrations (up to 0.5 g L). Confocal microscopy showed a successful uptake of nanocarriers by RAW 264.7 macrophages and a promising ability to silence green fluorescent protein (GFP) in HeLa cells. These results were confirmed by a high level of tumor necrosis factor-α (TNFα) knockdown (higher than 60%) in LPS-stimulated macrophages treated with the siRNA-loaded nanoparticles even in the FBS-containing medium, findings that reveal a good correlation between the degree of ionization of the polycations and the physicochemical properties of nanocarriers. Overall, this study provides an approach to enhance siRNA condensation by chitosan-based carriers and highlights the potential of these nanocarriers for in vivo studies.

摘要

如今,小干扰 RNA(siRNA)的治疗效率仍然受到能够将其携带到靶细胞内的基因治疗载体的效率的限制。在这项研究中,开发了基于低分子量壳聚糖的 siRNA 纳米载体,该载体接枝有不同比例(5 至 55%)的二异丙基乙胺(DIPEA)基团,这使得可以精确控制聚阳离子在 pH7.4 时的离解程度。这种方法使得有可能获得在生理条件下(pH7.4 和离子强度 150mmolL)具有小尺寸(100-200nm)、正表面电荷和增强胶体稳定性(长达 24 小时)的 siRNA 纳米载体。此外,PEG 化提高了纳米颗粒的稳定性,即使在含有白蛋白的介质中,纳米颗粒也能保持其胶体稳定性和纳米尺寸。壳聚糖衍生物在高 N/P 比和聚合物浓度(高达 0.5gL)下,在成纤维细胞(NIH/3T3)和巨噬细胞(RAW264.7)中均表现出非细胞毒性作用。共焦显微镜显示,纳米载体被 RAW264.7 巨噬细胞成功摄取,并在 HeLa 细胞中具有沉默绿色荧光蛋白(GFP)的良好能力。在用负载 siRNA 的纳米颗粒处理的 LPS 刺激的巨噬细胞中,肿瘤坏死因子-α(TNFα)的敲低水平(高于 60%)证实了这些结果,即使在含有 FBS 的介质中,也发现聚阳离子的离解程度与纳米载体的物理化学性质之间存在良好的相关性。总的来说,这项研究提供了一种通过基于壳聚糖的载体增强 siRNA 凝聚的方法,并强调了这些纳米载体在体内研究中的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/0efa7dd4ea0e/marinedrugs-20-00476-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/45e861a11a3e/marinedrugs-20-00476-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/f03aa13e05ec/marinedrugs-20-00476-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/39f61b7cce96/marinedrugs-20-00476-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/dd46ada8f2a7/marinedrugs-20-00476-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/f2acdf2ef3c1/marinedrugs-20-00476-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/26b701519ee4/marinedrugs-20-00476-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/8ef0cfb21076/marinedrugs-20-00476-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/842e37cac16b/marinedrugs-20-00476-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/03e94351edb1/marinedrugs-20-00476-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/0efa7dd4ea0e/marinedrugs-20-00476-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/45e861a11a3e/marinedrugs-20-00476-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/f03aa13e05ec/marinedrugs-20-00476-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/39f61b7cce96/marinedrugs-20-00476-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/dd46ada8f2a7/marinedrugs-20-00476-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/f2acdf2ef3c1/marinedrugs-20-00476-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/26b701519ee4/marinedrugs-20-00476-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/8ef0cfb21076/marinedrugs-20-00476-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/842e37cac16b/marinedrugs-20-00476-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/03e94351edb1/marinedrugs-20-00476-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d20/9330794/0efa7dd4ea0e/marinedrugs-20-00476-g010.jpg

相似文献

1
Impact of Degree of Ionization and PEGylation on the Stability of Nanoparticles of Chitosan Derivatives at Physiological Conditions.在生理条件下,离解度和聚乙二醇化程度对壳聚糖衍生物纳米粒子稳定性的影响。
Mar Drugs. 2022 Jul 25;20(8):476. doi: 10.3390/md20080476.
2
Amphipathic chitosans improve the physicochemical properties of siRNA-chitosan nanoparticles at physiological conditions.两亲性壳聚糖可改善生理条件下 siRNA-壳聚糖纳米粒的理化性质。
Carbohydr Polym. 2019 Jul 15;216:332-342. doi: 10.1016/j.carbpol.2019.03.098. Epub 2019 Mar 28.
3
Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells.用于将小干扰RNA递送至癌细胞的基于单油酸甘油酯的隐形纳米载体。
Acta Biomater. 2015 Oct;25:216-29. doi: 10.1016/j.actbio.2015.07.032. Epub 2015 Jul 29.
4
Diethylaminoethyl- chitosan as an efficient carrier for siRNA delivery: Improving the condensation process and the nanoparticles properties.二乙氨基乙基壳聚糖作为 siRNA 递送的有效载体:改善凝聚过程和纳米颗粒性质。
Int J Biol Macromol. 2018 Nov;119:186-197. doi: 10.1016/j.ijbiomac.2018.07.072. Epub 2018 Jul 18.
5
Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.壳聚糖接枝-(PEI-β-环糊精)共聚物及其超分子聚乙二醇化用于 DNA 和 siRNA 的递送。
Biomaterials. 2011 Nov;32(32):8328-41. doi: 10.1016/j.biomaterials.2011.07.038. Epub 2011 Aug 15.
6
Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.离子交联叶酸-聚(乙二醇)-壳寡糖乳酸纳米粒介导的高效siRNA递送及肿瘤蓄积:用于潜在的靶向卵巢癌基因治疗
Eur J Pharm Sci. 2014 Feb 14;52:48-61. doi: 10.1016/j.ejps.2013.10.011. Epub 2013 Oct 29.
7
Impact of PEG Chain Length on the Physical Properties and Bioactivity of PEGylated Chitosan/siRNA Nanoparticles in Vitro and in Vivo.聚乙二醇链长对壳聚糖/siRNA 纳米粒物理性质和体内外生物活性的影响。
ACS Appl Mater Interfaces. 2017 Apr 12;9(14):12203-12216. doi: 10.1021/acsami.6b16556. Epub 2017 Apr 3.
8
In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice.叶酸-聚乙二醇-壳聚糖-二乙氨基乙基/小干扰RNA纳米颗粒对关节炎小鼠体内肿瘤坏死因子α沉默的治疗效果
Int J Nanomedicine. 2018 Jan 12;13:387-402. doi: 10.2147/IJN.S146942. eCollection 2018.
9
Fine-tuned PEGylation of chitosan to maintain optimal siRNA-nanoplex bioactivity.对壳聚糖进行优化的聚乙二醇化处理以保持最佳的 siRNA 纳米复合物的生物活性。
Carbohydr Polym. 2016 Jun 5;143:25-34. doi: 10.1016/j.carbpol.2016.01.010. Epub 2016 Jan 8.
10
Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes.聚乙二醇链长对聚乙烯亚胺接枝聚乙二醇嵌段共聚物/小干扰RNA复合物理化性质和生物学性质的影响
Bioconjug Chem. 2006 Sep-Oct;17(5):1209-18. doi: 10.1021/bc060129j.

本文引用的文献

1
Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug.小干扰RNA分子的生物技术进化:从实验工具到精制药物。
Pharmaceuticals (Basel). 2022 May 5;15(5):575. doi: 10.3390/ph15050575.
2
Potential Applications of Chitosan-Based Nanomaterials to Surpass the Gastrointestinal Physiological Obstacles and Enhance the Intestinal Drug Absorption.基于壳聚糖的纳米材料在克服胃肠道生理障碍及增强肠道药物吸收方面的潜在应用
Pharmaceutics. 2021 Jun 15;13(6):887. doi: 10.3390/pharmaceutics13060887.
3
Gene therapy avenues and COVID-19 vaccines.
基因治疗途径与新冠疫苗。
Genes Immun. 2021 Jun;22(2):120-124. doi: 10.1038/s41435-021-00136-6. Epub 2021 Jun 2.
4
Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers.两亲性聚合物纳米载体的细胞内化及细胞内命运的探索与见解
Acta Pharm Sin B. 2021 Apr;11(4):903-924. doi: 10.1016/j.apsb.2021.02.019. Epub 2021 Feb 27.
5
Characterization of chitosan with different degree of deacetylation and equal viscosity in dissolved and solid state - Insights by various complimentary methods.不同脱乙酰度且等黏度壳聚糖在溶解态和固态下的结构特征 - 多种互补方法的见解。
Int J Biol Macromol. 2021 Feb 28;171:242-261. doi: 10.1016/j.ijbiomac.2021.01.010. Epub 2021 Jan 6.
6
Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.理解影响基于壳聚糖的纳米粒子-蛋白冠相互作用和药物传递应用的因素。
Molecules. 2020 Oct 16;25(20):4758. doi: 10.3390/molecules25204758.
7
Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer.用于CD44靶向小干扰RNA递送以治疗膀胱癌的可自交联壳聚糖-透明质酸二醛纳米颗粒
Bioact Mater. 2020 Sep 8;6(2):433-446. doi: 10.1016/j.bioactmat.2020.08.019. eCollection 2021 Feb.
8
Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments.用于眼部给药制剂的壳聚糖及其衍生物:最新进展与发展
Polymers (Basel). 2020 Jul 8;12(7):1519. doi: 10.3390/polym12071519.
9
Therapeutic siRNA: state of the art.治疗性 siRNA:最新进展。
Signal Transduct Target Ther. 2020 Jun 19;5(1):101. doi: 10.1038/s41392-020-0207-x.
10
Functionalized-chitosan/quantum dot nano-hybrids for nanomedicine applications: towards biolabeling and biosorbing phosphate metabolites.用于纳米医学应用的功能化壳聚糖/量子点纳米杂化物:用于生物标记和生物吸附磷酸盐代谢物
J Mater Chem B. 2013 Mar 28;1(12):1696-1711. doi: 10.1039/c3tb00498h. Epub 2013 Feb 7.